Breast implantation surgical procedure has evolved greatly with the growing demand for the surgeries. Women with the high preference for enhancing the aesthetic appeal contribute principally to the revenue of the breast implantation market. According to FDA, women above the age of 18 years can undergo the breast augmentation surgeries.
Rising incidence of breast cancer is a significant driver leading to growth of the market. In severe cases, prevention of this disease includes mastectomy surgery that requires removal of entire organ. In addition, reform or reconstruction of the organ is considered as useful option for treatment of the disease. The procedure involves reconstructing the shape of removed organ. Thus, with the rising number of reform cases, there is growing demand for the breast implantation.
The American Society of Plastic Surgeons stated that breast amplification is one of the top five cosmetic procedures performed in the U.S. As per the organization, 279,143 number of processes related to augmentation had taken place in the U.S. Hence, with huge number of such cases, the growth of the market is expected to increase over the coming years.Segment Overview
Based on product segment, silicone implants commanded largest market share in 2019 due to the fact that the devices tend to be similar to the natural breast tissue. Gummy implant gives natural shape to the recreated breast. The product segment does not pose any risk for disorders related with the immune system.
Moreover, silicone implants are anticipated to showcase the highest growth over forecast period owing to the soft texture this feature reduces the risk of formation of solid scar tissue around implantation. Additionally, gummy implants also have low risk of wrinkling.Regional Overview
In 2019, North America lead the market owing to increasing healthcare spending in U.S. and the rising demand for various cosmetic surgical procedures associated with improvement of aesthetics in the country. Moreover, growing prevalence of breast cancer in the region is also anticipated to strengthen the growth of market.
Europe also commanded t significant share in 2019 owing to huge awareness levels concerning cosmetic surgeries in the region. Furthermore, introduction of large number of various cosmetology clinics in Europe has further supported the growth of the regional market.
Asia Pacific is likely to showcase lucrative growth during the forecast period. This is due to rising disposable income in developing countries. Furthermore, the region provides huge opportunity to the low-cost treatments in medical tourism. Therefore, the aforementioned factors are projected to drive the market growth.Competitor overview
The main strategies of the companies include mergers & acquisitions, new product development, and geographical expansions. For example, in 2016, Allergan plc had U.S. FDA approval for NATRELLE INSPIRA Cohesive implants, a new introduction in the gummy breast implants category.Key Players
- GC Aesthetics;
- GROUPE SEBBIN SAS;
- Mentor Worldwide LLC;
- Sientra, Inc.;
- Polytech Health & Aesthetics GmbH;
- Establishment Labs S.A.;
- Shanghai Kangning Medical Supplies Ltd.;
- Guangzhou Wanhe Plastic Materials Co., Ltd.;
- LABORATOIRES ARION;
- HANSBIOMED CO. LTD.
- Cosmetic Surgery
- Reconstructive Surgery
By End User
- Ambulatory Surgical Centers
- Cosmetology Clinics
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Rest of LAMEA